London (PRWEB UK) 5 November 2012
SMi’s Pharmaceutical Microbiology conference taking place on the 30th & 31st January London will provide attendees with an expert and highly accredited speaker line up including 13 pharma speakers who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry.
SMi is pleased to confirm Olivier Chancel, Head of Pharmaceutical Support, Merial, Sanofi-Aventis as a speaker at the upcoming event
He will address global and rationalised approach to control container closure integrity at the best price, microbial ingress testing to validate the stopper / bottle association and the crimping parameters, seal force testing to control the line in sealing process through the filling of commercial batches and universal vacuum test to confirm container and closure system integrity as part of the stability protocol.
Key topics for 2013 include:
Investigative technologies – New effective microbial methods and risk assessments
Sterility Assurance – Discuss risk assessment and learn how to reduce cost when products are contaminated
Contamination control– The emerging field of plasma medicine and biocidal plasmas
Rapid microbial methods – Share a global and rationalised approach to control container closure integrity at the best price
For more information visit http://www.smi-online.co.uk/goto/pharma-microbiology45.asp alternatively contact Fateja Begum on +44 0 207 827 6184 or email on fbegum (at) smi-online (dot) co (dot) uk